Emergent BioSolutions traded at $34.36 this Friday May 20th, increasing $2.67 or 8.43 percent since the previous trading session. Looking back, over the last four weeks, Emergent BioSolutions gained 16.09 percent. Over the last 12 months, its price fell by 41.41 percent. Looking ahead, we forecast Emergent BioSolutions to be priced at 33.51 by the end of this quarter and at 31.09 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
34.36
Daily Change
8.43%
Yearly
-41.41%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Acadia Pharmaceuticals 16.70 -0.13 -0.77% -22.61%
Akebia Therapeutics 0.33 -0.02 -5.20% -90.60%
ALKERMES 30.39 0.91 3.09% 38.64%
Alnylam Pharmaceuticals 132.06 2.70 2.09% -5.74%
Amarin 1.43 -0.02 -1.04% -68.75%
ANI Pharmaceuticals 30.59 0.67 2.24% -13.54%
BioMarin Pharmaceutical 80.58 1.30 1.64% 1.85%
Coherus Biosciences 8.21 0.30 3.85% -39.06%
Chimerix 2.29 0.09 4.09% -71.01%
Emergent BioSolutions 34.36 2.67 8.43% -41.41%
Exact Sciences 54.22 0.22 0.41% -48.72%
Exelixis 17.56 0.12 0.69% -27.83%
Glaxosmithkline 44.32 0.76 1.74% 13.55%
Heron Therapeutics 3.70 0.13 3.68% -74.03%
Intercept Pharmaceuticals 17.20 0.04 0.23% -0.41%
Immunogen 3.67 0.14 3.82% -42.82%
Ionis Pharmaceuticals 39.15 0.02 0.05% 7.08%
Ironwood Pharmaceuticals 11.50 0.04 0.35% -7.48%
Jazz Pharmaceuticals 150.07 0.54 0.36% -15.97%
Lonza Group 553.40 19.60 3.67% -2.54%
Lexicon Pharmaceuticals 1.72 0.05 2.69% -60.57%
Merck & Co 93.58 1.49 1.62% 18.19%
Moderna Inc 136.35 -7.03 -4.90% -15.55%
Myriad Genetics 21.69 0.15 0.70% -20.69%
Neurocrine Biosciences 85.94 0.57 0.67% -8.93%
Nektar Therapeutics 4.00 0.09 2.30% -77.96%
Opko Health 3.06 0.07 2.34% -17.07%
Pacira 63.72 0.68 1.08% -3.91%
Pfizer 52.49 1.84 3.63% 31.39%
PTC Therapeutics 32.72 0.22 0.68% -16.51%
Sanofi 102.26 2.20 2.20% 15.90%
Seattle Genetics 141.31 -1.32 -0.93% -9.02%
Sarepta Therapeutics 70.16 0.94 1.36% -12.53%
Teva Pharmaceutical Industries 8.48 0.17 2.05% -21.26%
United Therapeutics 186.61 0.30 0.16% -1.12%
Vanda Pharmaceuticals 10.06 0.17 1.72% -45.77%
Xoma 18.17 0.10 0.55% -41.95%

Indexes Price Day Year
US2000 1773 -2.96 -0.17% -19.95%
US400 2385 -6.53 -0.27% -11.34%

Emergent BioSolutions
Emergent BioSolutions Inc. is a life sciences company focused on providing civilian and military populations with a portfolio of preparedness and response products and solutions that address accidental, deliberate and naturally occurring public health threats (PHTs). The Company is focused on five PHT categories: Chemical, Biological, Radiological, Nuclear and Explosives (CBRNE); emerging infectious diseases (EID); travel health; emerging health crises; acute/emergency care; and contract development and manufacturing (CDMO). It operates through four business units, which includes three product business units: Vaccines, Devices, Therapeutics; and one services business unit: CDMO. The Company's contract development and manufacturing service offerings cover development services, drug substance manufacturing and drug product manufacturing across the pharmaceutical and biotechnology industries as well as the United States Government (USG) and non-Governmental organizations.